Shanghai Microport Endovascular Medtech Co (SHSE:688016) Construction In Progress: ¥632 Mil (As of Mar. 2026)


SHSE:688016 Shanghai Microport Endovascular Medtech Co Ltd SHSE:688016
100 GF Score
Price ¥93.70
GF Value ¥118.63
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shanghai Microport Endovascular Medtech Co Construction In Progress?

Shanghai Microport Endovascular Medtech Co SHSE:688016 +3.55% 100 Construction In Progress is ¥632 Mil as of Mar. 2026. GuruFocus rates SHSE:688016 with a GF Score™ of 100/100 and a GF Value™ of ¥118.63 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Shanghai Microport Endovascular Medtech Co's quarterly construction in progress increased from Sep. 2025 (¥537 Mil) to Dec. 2025 (¥607 Mil) and increased from Dec. 2025 (¥607 Mil) to Mar. 2026 (¥632 Mil).

Shanghai Microport Endovascular Medtech Co's annual construction in progress increased from Dec. 2023 (¥206 Mil) to Dec. 2024 (¥288 Mil) and increased from Dec. 2024 (¥288 Mil) to Dec. 2025 (¥607 Mil).

Shanghai Microport Endovascular Medtech Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Shanghai Microport Endovascular Medtech Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Microport Endovascular Medtech Co Construction In Progress Chart

Shanghai Microport Endovascular Medtech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.25 100.65 205.96 288.27 606.65

Shanghai Microport Endovascular Medtech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 301.90 415.89 536.54 606.65 632.19
SHSE:688016
100GF Score
Shanghai Microport Endovascular Medtech Co Ltd SHSE:688016
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Microport Endovascular Medtech Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥632 Mil mean?
Shanghai Microport Endovascular Medtech Co (SHSE:688016) has a Construction In Progress of ¥632 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Shanghai Microport Endovascular Medtech Co and its competitors.
Is Shanghai Microport Endovascular Medtech Co's Construction In Progress too high?
Shanghai Microport Endovascular Medtech Co's current Construction In Progress is ¥632 Mil. Overall, Shanghai Microport Endovascular Medtech Co has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Microport Endovascular Medtech Co's Construction In Progress compare to ABT and SYK?
Shanghai Microport Endovascular Medtech Co's Construction In Progress of ¥632 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Shanghai Microport Endovascular Medtech Co and its competitors. Shanghai Microport Endovascular Medtech Co's current Construction In Progress is ¥632 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Microport Endovascular Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Microport Endovascular Medtech Co (SHSE:688016) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥118.63, compared to a current price of ¥93.70 — trading 21% below its estimated fair value. The current Construction In Progress is ¥632 Mil. Shanghai Microport Endovascular Medtech Co's overall GF Score™ is 100/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Shanghai Microport Endovascular Medtech Co (SHSE:688016), the current Construction In Progress is ¥632 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Microport Endovascular Medtech Co (SHSE:688016) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Microport Endovascular Medtech Co stock appears to be undervalued. The current stock price of ¥93.70 is trading 21% below its estimated GF Value™ of ¥118.63. GuruFocus considers Shanghai Microport Endovascular Medtech Co to be Modestly Undervalued.

Key valuation signals for SHSE:688016:

  • Construction In Progress: ¥632 Mil
  • GF Value™: ¥118.63 vs. price of ¥93.70 (21% below fair value)
  • GF Score™: 100/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Microport Endovascular Medtech Co Business Description

Address No. 1 Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 201318
Shanghai Microport Endovascular Medtech Co Ltd is engaged in the Research, development, production and sales of interventional medical devices for the aorta and peripheral blood vessels.
100GF Score

Get the complete analysis for SHSE:688016

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥93.70
Price
¥118.63
GF Value